These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 9879598

  • 1. Urine activity of cathepsin B, collagenase and urine excretion of TGF-beta 1 and fibronectin in membranous glomerulonephritis.
    Senatorski G, Paczek L, Sułowicz W, Gradowska L, Bartłomiejczyk I.
    Res Exp Med (Berl); 1998 Dec; 198(4):199-206. PubMed ID: 9879598
    [Abstract] [Full Text] [Related]

  • 2. [Activity of cathepsin B and collagenase in urine and excretion of fibronectin and TGF-beta 1 in urine of patients with membranous glomerulonephritis].
    Senatorski G, Paczek L, Sułowicz W, Gradowska L, Bartłomiejczyk I.
    Pol Arch Med Wewn; 1997 Sep; 98(9):206-12. PubMed ID: 9557072
    [Abstract] [Full Text] [Related]

  • 3. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis.
    Honkanen E, Teppo AM, Törnroth T, Groop PH, Grönhagen-Riska C.
    Nephrol Dial Transplant; 1997 Dec; 12(12):2562-8. PubMed ID: 9430852
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor beta (TGF beta) activity in urine of patients with glomerulonephritis.
    Dominguez GC, Costa RS, Dantas M, Kimachi T, Coimbra TM.
    Braz J Med Biol Res; 1995 Oct; 28(10):1061-4. PubMed ID: 8634677
    [Abstract] [Full Text] [Related]

  • 5. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
    Bobkova IN, Chebotareva NV, Kozlovskaia LV, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2006 Oct; 78(5):9-14. PubMed ID: 16889042
    [Abstract] [Full Text] [Related]

  • 6. Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis.
    Kanai H, Mitsuhashi H, Ono K, Yano S, Naruse T.
    Nephron; 1994 Oct; 66(4):391-5. PubMed ID: 8015640
    [Abstract] [Full Text] [Related]

  • 7. Urinary transforming growth factor-beta in patients with glomerular diseases.
    Murakami K, Takemura T, Hino S, Yoshioka K.
    Pediatr Nephrol; 1997 Jun; 11(3):334-6. PubMed ID: 9203185
    [Abstract] [Full Text] [Related]

  • 8. Increased urinary transforming growth factor-beta(1) excretion in children with posterior urethral valves.
    MacRae Dell K, Hoffman BB, Leonard MB, Ziyadeh FN, Schulman SL.
    Urology; 2000 Aug 01; 56(2):311-4. PubMed ID: 10925100
    [Abstract] [Full Text] [Related]

  • 9. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
    Haramaki R, Tamaki K, Fujisawa M, Ikedo H, Haramaki N, Okuda S.
    Am J Kidney Dis; 2001 Dec 01; 38(6):1191-8. PubMed ID: 11728950
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sodium bicarbonate treatment reduces renal injury, renal production of transforming growth factor-beta, and urinary transforming growth factor-beta excretion in rats with doxorubicin-induced nephropathy.
    Baroni EA, Costa RS, Volpini R, Coimbra TM.
    Am J Kidney Dis; 1999 Aug 01; 34(2):328-37. PubMed ID: 10430982
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
    Agarwal R, Siva S, Dunn SR, Sharma K.
    Am J Kidney Dis; 2002 Mar 01; 39(3):486-92. PubMed ID: 11877567
    [Abstract] [Full Text] [Related]

  • 16. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis.
    Honkanen EO, Teppo AM, Grönhagen-Riska C.
    Kidney Int; 2000 Jun 01; 57(6):2343-9. PubMed ID: 10844604
    [Abstract] [Full Text] [Related]

  • 17. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, Pisano L, D'Amico G.
    Am J Kidney Dis; 2001 Aug 01; 38(2):240-8. PubMed ID: 11479148
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.
    Park HC, Xu ZG, Choi S, Goo YS, Kang SW, Choi KH, Ha SK, Lee HY, Han DS.
    Nephrol Dial Transplant; 2003 Jun 01; 18(6):1115-21. PubMed ID: 12748343
    [Abstract] [Full Text] [Related]

  • 20. Intraglomerular fibronectin and laminin turn-over in chronically rejected kidney allografts in humans.
    Paczek L, Bartłomiejczyk I, Gradowska L, Szmidt J, Rowiński W, Gaciong Z, Heidland A, Laskowska-Klita T.
    Ann Transplant; 1996 Jun 01; 1(1):41-3. PubMed ID: 9869936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.